DMD, DSK act on IPO-bound OneSource’s $100 mln fundraise
BY Nimitt Dixit |
DMD Advocates has advised HBM Healthcare Investments and other associated investors in leading OneSource Specialty Pharma’s $100 million fundraising through a pre-listing round, with DSK Legal representing OneSource on the deal.